Free Trial

Apollomics (APLMW) Competitors

$0.02 +0.00 (+0.45%)
As of 08/12/2025 03:38 PM Eastern

APLMW vs. ATNFW, SXTPW, DRTSW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPW

Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry.

Apollomics vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
ApollomicsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, 180 Life Sciences had 3 more articles in the media than Apollomics. MarketBeat recorded 4 mentions for 180 Life Sciences and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat 180 Life Sciences' score of 1.54 indicating that Apollomics is being referred to more favorably in the news media.

Company Overall Sentiment
180 Life Sciences Very Positive
Apollomics Very Positive

Summary

180 Life Sciences and Apollomics tied by winning 1 of the 2 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APLMW vs. The Competition

MetricApollomicsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$137.28M$5.49B$9.69B
Dividend YieldN/A3.74%4.64%4.14%
P/E RatioN/A3.7730.4025.31
Price / SalesN/A4,198.12448.16101.62
Price / CashN/A13.1937.7258.50
Price / BookN/A39.548.296.01
Net IncomeN/A-$90.99M$3.26B$265.10M
7 Day PerformanceN/A-0.15%1.56%1.39%
1 Month PerformanceN/A2.73%3.75%2.43%
1 Year PerformanceN/A175.39%40.94%24.74%

Apollomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APLMW
Apollomics
N/A$0.02
+0.5%
N/A+101.8%$0.00N/A0.0059Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+1.0%
N/A+1,183.1%$0.00N/A0.007News Coverage
SXTPW
60 Degrees Pharmaceuticals
N/A$0.06
-44.7%
N/A+195.5%$0.00$665.45K0.002Gap Up
DRTSW
Alpha Tau Medical
N/A$0.27
-0.4%
N/A+62.6%$0.00N/A0.0080
BCTXW
BriaCell Therapeutics
N/A$0.03
-27.9%
N/A-84.5%$0.00N/A0.008Gap Down
High Trading Volume
CDIOW
Cardio Diagnostics
N/A$0.01
-2.1%
N/A-58.7%$0.00$19.90K0.007Negative News
CELUW
Celularity
N/A$0.05
flat
N/AN/A$0.00$54.22M0.00220Positive News
Gap Down
CEROW
CERo Therapeutics
N/A$0.02
-0.5%
N/A-53.8%$0.00N/A0.008
CINGW
Cingulate
N/A$0.06
-51.1%
N/A+750.0%$0.00N/A0.0020Gap Down
High Trading Volume
CLNNW
Clene
N/A$0.04
-6.4%
N/A-43.9%$0.00$350K0.00100Gap Down
COEPW
Coeptis Therapeutics
N/A$0.02
-13.6%
N/A-19.7%$0.00$62.87K0.004Gap Down

Related Companies and Tools


This page (NASDAQ:APLMW) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners